Dr. Sanjay Maraboyina, MD

Dr. Maraboyina practices at UAMS Medical Center in Little Rock, Arkansas, part of University of Arkansas for Medical Sciences.

Dr. Maraboyina's NPI, 1730388166, was assigned on July 16, 2007. Dr. Maraboyina graduated from University of Cincinnati College of Medicine in 2007. Dr. Maraboyina holds Arkansas license E-8213.

Dr. Maraboyina's primary practice is UAMS Medical Center, at 4301 West Markham Street Mail Slot 612, Little Rock, AR 72205 in Pulaski County. The practice phone is (501) 686-5000.

Dr. Maraboyina's primary practice is UAMS Medical Center in Little Rock, Arkansas, part of University of Arkansas for Medical Sciences. The medical group on file is UAMS - University of Arkansas for Medical Sciences. Dmand AI also links Dr. Maraboyina to 4 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Maraboyina practices. Vendor and product names are available with a free account.

Radiation oncology is Dr. Maraboyina's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Maraboyina is licensed in Arkansas.

CMS data shows 3,039 Medicare services from Dr. Maraboyina across 18 procedure codes in 2024, for 283 Medicare patients. Medicare paid $756,333 for them. Every service was in an office.

CMS counts 283 Medicare patients who saw Dr. Maraboyina in 2024. The largest group is 65 to 74, with 134 patients. 75% of them have cancer, and 75% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Maraboyina's median patient age at 71, with 27% women.

In 2024, Dr. Maraboyina wrote 113 Medicare Part D claims for 44 patients. 89% of them were for generic drugs. CMS names the drug for 60 of them, across 1 drug with 11 or more claims each, at $932 in total drug cost. In 2023, CMS named 35 claims across 1 drug.

Dr. Maraboyina accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Maraboyina as offering telehealth.

Dmand AI links 17 papers to Dr. Maraboyina, published from 2017 to 2024. 2020 was the busiest year, with 4. The most frequent topics are SEER Program, Lung Neoplasms and Lung. Dr. Maraboyina has published most often in Cancers (Basel). Dr. Maraboyina's most frequent co-authors are Thomas Kim, MD, Jose Penagaricano, MD and Fen Xia, MD, PhD.

Dmand AI links Dr. Maraboyina to 8 clinical trials, 5 of them phase 3 studies. 8 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms and Carcinoma, Bronchogenic. NRG Oncology sponsors the most, 5.

CMS Open Payments shows 6 general payments to Dr. Maraboyina from 5 drug and device companies from 2017 to 2023. Food and beverage make up the largest share, 100% of the total. IBA Proton Therapy, Inc. paid the most, $169.

Dr. Maraboyina graduated from University of Cincinnati College of Medicine in 2007.